Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue-Reference-Cited by-同舟云学术

Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue

Published:2010-02 Issue:2 Volume:75 Page:110-118
ISSN:0001-2815
Container-title:Tissue Antigens
language:en
Short-container-title:

Author:

SÃ¡enz-LÃ³pez P.,Gouttefangeas C.,Hennenlotter J.,Concha A.,Maleno I.,Ruiz-Cabello F.,CÃ³zar J. M.,Tallada M.,Stenzl A.,Rammensee H.-G.,Garrido F.,Cabrera T.

Publisher

Wiley

Subject

Genetics,Biochemistry,Immunology,General Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-0039.2009.01409.x/fullpdf

Reference47 articles.

1. Cancer statistics 1999;Landis;CA Cancer J Clin,1999

2. Chemoimmunotherapy in the systemic treatment of advanced renal carcinoma;Atzpodien;Urologe A,1999

3. Renal cell carcinoma: management of advanced disease;Figlin;J Urol,1999

4. Estado actual de la inmunoterapia en el cÃ¡ncer renal diseminado;Cozar;Rev Urol,2002

5. The Heidelberg classification of renal cell tumours;Kovacs;J Pathol,1997

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential protumor function of CD74 in clear cell renal cell carcinoma;Human Cell;2024-07-30

2. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine;Nature Reviews Clinical Oncology;2024-02-29

3. HLA Genes and Molecules;The Major Histocompatibility Complex (MHC/ HLA) in Medicine;2024

4. Proteogenomics Reveal the Overexpression of HLA-I in Cancer;Journal of Proteome Research;2023-10-19

5. The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes;Clinical Cancer Research;2022-07-21